ATG16L1 and metabolic disease: To summarize, the findings of the present study demonstrated that dysregulation of the FTO/m6A/ATG16L1 axis impairs autophagy in meniscus cells, thereby promoting bioenergetic metabolic disorders and accelerating meniscus degeneration and OA (Figure 7h).